FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
Post a Comment
FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
Post a Comment
FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
Post a Comment
FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information:
verify here.